Blog
Blog
Need for speed: the key to successful multi-market product launches
Launching a new drug in the European marketplace presents a variety of unique challenges. Numerous official working languages, complex independent regulatory requirements combined with an overarching framework, and the intricacy and scale of distribution are all characteristics of an EU launch.
Continue Reading
Blog
Low-volume / small-batch packaging challenges (in both the US and EU)
Meeting the small-batch pharma packaging challenge Medications are becoming far more specialized and personalized and these specialty drug products continue to emerge as the…
Continue Reading
Blog
Supporting the rapid launch of pharmaceutical and biopharma products: a contract packaging perspective
Product launches see pharma and biotech companies handing over drugs with incredible value, both commercially and to the health of patients globally, to contract…
Continue Reading
Blog
Technology and innovation: developing virtual audits to continue supporting clients throughout the pandemic
Technology was key to continuing business as usual throughout the pandemic wherever possible. At Sharp, part of UDG Healthcare, this meant being creative and…
Continue Reading
Blog
COVID-19: A catalyst for change in global clinical trials
The COVID-19 pandemic has exposed some significant frailties in the physical clinical supply chain. As governments, medical professionals and life science organisations around the…
Continue Reading
Blog
Sharp Expands its Commercial Capabilities to UK Facility
During 2018, Sharp Clinical invested $36 million in new, dedicated facilities in both the US and the UK. Another £1 million has been invested…
Continue Reading